Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Catalyst Pharmaceutical Partners, Inc.    CPRX   US14888U1016

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/14/2014 10/15/2014 10/16/2014 10/17/2014 10/20/2014 Date
2.37(c) 2.44(c) 2.43(c) 2.48(c) 2.45(c) Last
1 435 144 620 082 718 687 369 537 463 826 Volume
-4.82% +2.95% -0.41% +2.06% -1.21% Change
More quotes
Company
Catalyst Pharmaceutical Partners, Inc. is a development-stage specialty pharmaceutical company, which focuses on the development and commercialization of prescription drugs targeting addiction and diseases of the central nervous system with a focus on the treatment of drug addiction and... 
Surperformance© rating of Catalyst Pharmaceutical Pa
Trading Rating : Investor Rating : -
More about the company
Chart CATALYST PHARMACEUTICAL PA
Duration : Period :
Catalyst Pharmaceutical Pa Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 -
EBIT 2014 -13,4 M
Net income 2014 -13,6 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -15,4 M
Net income 2015 -15,1 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 165 M
More Financials
Latest news on CATALYST PHARMACEUTICAL PA
10/08 CATALYST PHARMACEUTICAL PARTNERS : Wednesday 10/8 Insider Buying Report: CPRX
10/08 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals to Present Top-Line Safety an..
10/02 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals to Present at 13th Annual BIO..
09/30DJMARKET SNAPSHOT : U.S. Stocks Limp Into October
09/30DJMARKET SNAPSHOT : Weak Housing Data Helps Push U.S. Stocks Lower
09/30DJMARKET SNAPSHOT : U.S. Stocks: Futures Up Ahead Of Home Prices, Consumer Confide..
09/30DJMARKET SNAPSHOT : U.S. Stocks: Futures Up Ahead Of Home Prices, Consumer Confide..
09/30DJMARKET SNAPSHOT : U.S. Stocks Rebound; Dow Flat Over Month
09/29 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces Positive Top-Line P..
09/04 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Appoints David D. Muth as Exe..
09/03 CATALYST PHARMACEUTICAL PARTNERS : to Present at Rodman & Renshaw's 16th Annual ..
09/02 CATALYST PHARMACEUTICAL PARTNERS : Initiates Phase 1(b) Safety and Tolerance Stu..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF